Gain of function in somatic TP53 mutations is associated with immune‐rich breast tumors and changes in tumor‐associated macrophages-Reference-Cited by-同舟云学术

Gain of function in somatic TP53 mutations is associated with immune‐rich breast tumors and changes in tumor‐associated macrophages

Published:2019-10-22 Issue:12 Volume:7 Page:
ISSN:2324-9269
Container-title:Molecular Genetics & Genomic Medicine
language:en
Short-container-title:Mol Genet Genomic Med

Author:

Behring Michael¹²^ORCID,Vazquez Ana I.³⁴,Cui Xiangqin⁵,Irvin Marguerite R.¹,Ojesina Akinyemi I.¹⁶⁷,Agarwal Sumit²,Manne Upender²⁷,Shrestha Sadeep¹⁷^ORCID

Affiliation:

1. Department of Epidemiology University of Alabama at Birmingham Birmingham AL USA

2. Department of Pathology and Surgery University of Alabama at Birmingham Birmingham AL USA

3. Institute for Quantitative Health Science and Engineering Michigan State University East Lansing MI USA

4. Department of Epidemiology and Biostatistics Michigan State University East Lansing MI USA

5. Department of Biostatistics and Bioinformatics Emory University Atlanta GA USA

6. HudsonAlpha Institute for Biotechnology Huntsville AL USA

7. Comprehensive Cancer Center University of Alabama at Birmingham Birmingham AL USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Genetics (clinical),Genetics,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mgg3.1001

Reference26 articles.

1. Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival

2. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

3. Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246

4. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

5. Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public neoantigens in breast cancer immunotherapy (Review);International Journal of Molecular Medicine;2024-06-17

2. The current advances of lncRNAs in breast cancer immunobiology research;Frontiers in Immunology;2023-06-05

3. Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma;The Oncologist;2023-05-09

4. Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer;npj Breast Cancer;2022-05-10

5. Inflammatory level under different p53 mutation status and the regulation role of curcumin in tumor microenvironment;Immunobiology;2022-03